Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
Go back to Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 7.65 +0.10 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.55 | 52 Week High | $2.43 | |||
| Open | $7.58 | 52 Week Low | $1.05 | |||
| Day High | $7.66 | P/E | N/A | |||
| Day Low | $7.45 | EPS | $-1.79 | |||
| Volume | 306,168 | |||||

